Neurofibromatosis-associated Tumor is very rare bone tumor. The investigator set up the biobank to ensure every patient has the chance to participate in future research
Samples of blood and other stored material such as slides,frozen tissues or leftover diagnostic material. Questionnaire information, including health history, growth and development, physical activity and family medical history information. If patients have been diagnosed with a neurofibromatosis-associated tumor or another condition the investigator is interested in， the investigator will ask the patient to release medical record information relating to diagnosis and treatment of neurofibromatosis-associated tumor, other cancers, blood disorders, and similar conditions.
Study Type
OBSERVATIONAL
Enrollment
300
Detected NF-1 gene expression pattern in neurofibromatosis-asociated tumor
To examine the neurofibromatosis type 1(NF-1) gene expression of the patients with neurofibromatosis-associated tumor
Time frame: 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.